Identifying the genomic landscape of EGFR-mutant lung cancers with CNS metastases
{{output}}
Background: Despite the intracranial efficacy of osimertinib, CNS metastases remain a major cause of morbidity and mortality in EGFR-mutant non-small cell lung cancer (NSCLC). The genomic drivers of CNS dissemination are poorly u... ...
